{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:20:29Z","timestamp":1790018429160,"version":"4.0.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.ahj.2018.07.021","type":"journal-article","created":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T22:20:00Z","timestamp":1533075600000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"special_numbering":"C","title":["Cardiovascular Outcomes Assessment of the MitraClip in Patients with Heart Failure and Secondary Mitral Regurgitation: Design and rationale of the COAPT trial"],"prefix":"10.1016","volume":"205","author":[{"given":"Michael J.","family":"Mack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William T.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JoAnn","family":"Lindenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven F.","family":"Bolling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted E.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Grayburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir R.","family":"Kapadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Scott","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Udelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Zile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"Gammie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Marc","family":"Gillinov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald D.","family":"Glower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Heimansohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh M.","family":"Suri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey T.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saibal","family":"Kar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil J.","family":"Weissman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg W.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9540","key":"10.1016\/j.ahj.2018.07.021_bb0005","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(06)69208-8","article-title":"Burden of valvular heart diseases: a population-based study","volume":"368","author":"Nkomo","year":"2006","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ahj.2018.07.021_bb0010","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jacc.2015.05.046","article-title":"Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 1: clinical trial design principles: a consensus document from the Mitral Valve Academic Research Consortium","volume":"66","author":"Stone","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ahj.2018.07.021_bb0015","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jacc.2008.02.084","article-title":"The current therapy for mitral regurgitation","volume":"52","author":"Carabello","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.ahj.2018.07.021_bb0020","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1136\/hrt.2011.225789","article-title":"Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy","volume":"97","author":"Rossi","year":"2011","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.ahj.2018.07.021_bb0025","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/eurheartj\/ehx402","article-title":"Refining the prognostic impact of functional mitral regurgitation in chronic heart failure","volume":"39","author":"Goliasch","year":"2018","journal-title":"Eur Heart J"},{"issue":"19","key":"10.1016\/j.ahj.2018.07.021_bb0030","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1093\/eurheartj\/ehs109","article-title":"Guidelines on the management of valvular heart disease (version 2012)","volume":"33","author":"Joint Task Force on the Management of Valvular Heart Disease of the European Society of C","year":"2012","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.ahj.2018.07.021_bb0035","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jacc.2017.03.011","article-title":"2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"70","author":"Nishimura","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ahj.2018.07.021_bb0040","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJMoa1512913","article-title":"Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation","volume":"374","author":"Goldstein","year":"2016","journal-title":"N Engl J Med"},{"issue":"36","key":"10.1016\/j.ahj.2018.07.021_bb0045","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","article-title":"2017 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"38","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J"},{"issue":"15","key":"10.1016\/j.ahj.2018.07.021_bb0050","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1009355","article-title":"Percutaneous repair or surgery for mitral regurgitation","volume":"364","author":"Feldman","year":"2011","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ahj.2018.07.021_bb0055","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jacc.2013.12.062","article-title":"Percutaneous mitral valve repair for mitral regurgitation in high-risk patients: results of the EVEREST II study","volume":"64","author":"Glower","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ahj.2018.07.021_bb0060","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jacc.2013.10.021","article-title":"Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after transcatheter mitral valve repair","volume":"64","author":"Lim","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ahj.2018.07.021_bb0065","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jacc.2013.08.723","article-title":"Prevalence and outcomes of unoperated patients with severe symptomatic mitral regurgitation and heart failure: comprehensive analysis to determine the potential role of MitraClip for this unmet need","volume":"63","author":"Goel","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ahj.2018.07.021_bb0070","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jacc.2015.05.049","article-title":"Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: Part 2: Endpoint definitions: a consensus document from the mitral valve academic research consortium","volume":"66","author":"Stone","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.ahj.2018.07.021_bb0075","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.jacc.2009.03.077","article-title":"Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort","volume":"54","author":"Feldman","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.ahj.2018.07.021_bb0080","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/j.jacc.2005.07.065","article-title":"Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial","volume":"46","author":"Feldman","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.ahj.2018.07.021_bb0085","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.echo.2007.02.003","article-title":"Echocardiographic guidance and assessment of percutaneous repair for mitral regurgitation with the Evalve MitraClip: lessons learned from EVEREST I","volume":"20","author":"Silvestry","year":"2007","journal-title":"J Am Soc Echocardiogr"},{"issue":"7","key":"10.1016\/j.ahj.2018.07.021_bb0090","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0894-7317(03)00335-3","article-title":"Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography","volume":"16","author":"Zoghbi","year":"2003","journal-title":"J Am Soc Echocardiogr"},{"issue":"10","key":"10.1016\/j.ahj.2018.07.021_bb0095","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.amjcard.2007.06.066","article-title":"Quantitative assessment of severity of mitral regurgitation by serial echocardiography in a multicenter clinical trial of percutaneous mitral valve repair","volume":"100","author":"Foster","year":"2007","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.ahj.2018.07.021_bb0100","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJMoa020233","article-title":"Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure","volume":"347","author":"Maisel","year":"2002","journal-title":"N Engl J Med"},{"issue":"2 Suppl","key":"10.1016\/j.ahj.2018.07.021_bb0105","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1067\/mhj.2003.152","article-title":"B-type natriuretic peptide: from bench to bedside","volume":"145","author":"Adams","year":"2003","journal-title":"Am Heart J"},{"issue":"8","key":"10.1016\/j.ahj.2018.07.021_bb0110","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.ejheart.2007.07.010","article-title":"Prognostic importance of plasma NT-pro BNP in chronic heart failure in patients treated with a beta-blocker: results from the Carvedilol Or Metoprolol European Trial (COMET) trial","volume":"9","author":"Olsson","year":"2007","journal-title":"Eur J Heart Fail"},{"issue":"24","key":"10.1016\/j.ahj.2018.07.021_bb0115","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1056\/NEJMoa013168","article-title":"Cardiac resynchronization in chronic heart failure","volume":"346","author":"Abraham","year":"2002","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.ahj.2018.07.021_bb0120","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","article-title":"Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure","volume":"350","author":"Bristow","year":"2004","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.ahj.2018.07.021_bb0125","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMoa050496","article-title":"The effect of cardiac resynchronization on morbidity and mortality in heart failure","volume":"352","author":"Cleland","year":"2005","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ahj.2018.07.021_bb0130","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/biostatistics\/kxl043","article-title":"Joint frailty models for recurring events and death using maximum penalized likelihood estimation: application on cancer events","volume":"8","author":"Rondeau","year":"2007","journal-title":"Biostatistics"},{"issue":"11","key":"10.1016\/j.ahj.2018.07.021_bb0135","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/(SICI)1097-0258(19990615)18:11<1341::AID-SIM129>3.0.CO;2-7","article-title":"Combining mortality and longitudinal measures in clinical trials","volume":"18","author":"Finkelstein","year":"1999","journal-title":"Stat Med"},{"issue":"2","key":"10.1016\/j.ahj.2018.07.021_bb0140","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/eurheartj\/ehr352","article-title":"The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities","volume":"33","author":"Pocock","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2018.07.021_bb0145","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1161\/CIRCULATIONAHA.107.747568","article-title":"Evolving applications for patient-centered health status measures","volume":"118","author":"Spertus","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2018.07.021_bb0150","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ahj.2011.09.027","article-title":"Relationships between changes in patient-reported health status and functional capacity in outpatients with heart failure","volume":"163","author":"Flynn","year":"2012","journal-title":"Am Heart J"},{"issue":"25","key":"10.1016\/j.ahj.2018.07.021_bb0155","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1016\/j.jacc.2012.08.1010","article-title":"6-min walk test provides prognostic utility comparable to cardiopulmonary exercise testing in ambulatory outpatients with systolic heart failure","volume":"60","author":"Forman","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"10.1016\/j.ahj.2018.07.021_bb0160","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1161\/01.CIR.103.13.1759","article-title":"Ischemic mitral regurgitation : long-term outcome and prognostic implications with quantitative Doppler assessment","volume":"103","author":"Grigioni","year":"2001","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ahj.2018.07.021_bb0165","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1067\/mhj.2002.123575","article-title":"Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction","volume":"144","author":"Koelling","year":"2002","journal-title":"Am Heart J"},{"issue":"5","key":"10.1016\/j.ahj.2018.07.021_bb0170","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0002-9149(02)03301-5","article-title":"Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure","volume":"91","author":"Trichon","year":"2003","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.ahj.2018.07.021_bb0175","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0002-9149(02)03172-7","article-title":"Prevalence and severity of mitral regurgitation in chronic systolic heart failure","volume":"91","author":"Robbins","year":"2003","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.ahj.2018.07.021_bb0180","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ahj.2003.07.010","article-title":"Importance of echocardiography in patients with severe nonischemic heart failure: the second Prospective Randomized Amlodipine Survival Evaluation (PRAISE-2) echocardiographic study","volume":"147","author":"Cabell","year":"2004","journal-title":"Am Heart J"},{"issue":"10","key":"10.1016\/j.ahj.2018.07.021_bb0185","first-page":"797","article-title":"Mitral insufficiency and morbidity and mortality in left ventricular dysfunction","volume":"23","author":"Baskett","year":"2007","journal-title":"Can J Cardiol"},{"issue":"4","key":"10.1016\/j.ahj.2018.07.021_bb0190","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/eurjhf\/hfq014","article-title":"Prognostic implications of functional mitral regurgitation according to the severity of the underlying chronic heart failure: a long-term outcome study","volume":"12","author":"Bursi","year":"2010","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"10.1016\/j.ahj.2018.07.021_bb0195","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S1010-7940(01)00952-6","article-title":"A prospective study of changes in the quality of life of patients following mitral valve repair and replacement","volume":"20","author":"Goldsmith","year":"2001","journal-title":"Eur J Cardiothorac Surg"},{"issue":"2","key":"10.1016\/j.ahj.2018.07.021_bb0200","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/hrt.2008.160010","article-title":"Predicting outcome after valve replacement","volume":"96","author":"Rimington","year":"2010","journal-title":"Heart"},{"issue":"6","key":"10.1016\/j.ahj.2018.07.021_bb0205","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/heart.83.6.645","article-title":"Health related quality of life and psychological wellbeing in patients with dilated cardiomyopathy","volume":"83","author":"Steptoe","year":"2000","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.ahj.2018.07.021_bb0210","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cardfail.2008.10.003","article-title":"Acceptability and psychometric properties of the Minnesota Living With Heart Failure Questionnaire among patients undergoing heart valve surgery: validation and comparison with SF-36","volume":"15","author":"Supino","year":"2009","journal-title":"J Card Fail"},{"issue":"12","key":"10.1016\/j.ahj.2018.07.021_bb0215","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.jacc.2015.02.009","article-title":"Secondary mitral regurgitation in heart failure: pathophysiology, prognosis, and therapeutic considerations","volume":"65","author":"Asgar","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ahj.2018.07.021_bb0220","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.cardfail.2014.01.010","article-title":"Functional mitral regurgitation: therapeutic strategies for a ventricular disease","volume":"20","author":"Punnoose","year":"2014","journal-title":"J Card Fail"},{"issue":"18","key":"10.1016\/j.ahj.2018.07.021_bb0225","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1161\/01.CIR.0000146336.92331.D1","article-title":"Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure","volume":"110","author":"Abraham","year":"2004","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ahj.2018.07.021_bb0230","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1056\/NEJM200103223441202","article-title":"Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay","volume":"344","author":"Cazeau","year":"2001","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.ahj.2018.07.021_bb0235","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/S0735-1097(03)01042-8","article-title":"Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias","volume":"42","author":"Higgins","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"10.1016\/j.ahj.2018.07.021_bb0240","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1161\/01.CIR.0000065226.24159.E9","article-title":"Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure","volume":"107","author":"St John Sutton","year":"2003","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.ahj.2018.07.021_bb0245","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ahj.2018.07.021_bb0255","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1312808","article-title":"Mitral-valve repair versus replacement for severe ischemic mitral regurgitation","volume":"370","author":"Acker","year":"2014","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.ahj.2018.07.021_bb0260","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1056\/NEJMoa1410490","article-title":"Surgical treatment of moderate ischemic mitral regurgitation","volume":"371","author":"Smith","year":"2014","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ahj.2018.07.021_bb0265","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ijcard.2012.05.027","article-title":"Surgical treatment of functional mitral regurgitation","volume":"166","author":"Calafiore","year":"2013","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.ahj.2018.07.021_bb0270","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.athoracsur.2008.05.017","article-title":"Survival prognosis and surgical management of ischemic mitral regurgitation","volume":"86","author":"Milano","year":"2008","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.ahj.2018.07.021_bb0275","first-page":"17","article-title":"Does mitral valve intervention have an impact on late survival in ischemic cardiomyopathy?","volume":"8","author":"Silberman","year":"2006","journal-title":"Isr Med Assoc J"},{"issue":"3","key":"10.1016\/j.ahj.2018.07.021_bb0280","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jacc.2004.09.073","article-title":"Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction","volume":"45","author":"Wu","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"10.1016\/j.ahj.2018.07.021_bb0285","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/j.jacc.2007.02.043","article-title":"Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation","volume":"49","author":"Mihaljevic","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"10.1016\/j.ahj.2018.07.021_bb0290","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1016\/j.jacc.2015.10.018","article-title":"Randomized comparison of percutaneous repair and surgery for mitral regurgitation: 5-year results of EVEREST II","volume":"66","author":"Feldman","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ahj.2018.07.021_bb0295","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jacc.2011.08.067","article-title":"Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study","volume":"59","author":"Whitlow","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ahj.2018.07.021_bb0300","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/eurjhf\/hfr029","article-title":"MitraClip\u00ae therapy in patients with end-stage systolic heart failure","volume":"13","author":"Franzen","year":"2011","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"10.1016\/j.ahj.2018.07.021_bb0305","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/eurjhf\/hft046","article-title":"One year clinical efficacy and reverse cardiac remodelling in patients with severe mitral regurgitation and reduced ejection fraction after MitraClip implantation","volume":"15","author":"Pleger","year":"2013","journal-title":"Eur J Heart Fail"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870318302321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870318302321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:00:06Z","timestamp":1757570406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870318302321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":60,"alternative-id":["S0002870318302321"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2018.07.021","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular Outcomes Assessment of the MitraClip in Patients with Heart Failure and Secondary Mitral Regurgitation: Design and rationale of the COAPT trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2018.07.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}